This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ASHTON L. WELSH, M.D.; MITCHELL EDE, M.D.

AMA Arch Derm. 1957;76(4):466-470.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Benactyzine hydrochloride (Suavitil) is a member of that group of anticholinergic substances, several of which have selective activity upon various functions of the brain. This hydrochloride of the diethylaminoethyl ester of benzilic acid is represented by the following structural formula:

The drug, first prepared in Switzerland in 1936,^* was recently studied by investigators in Scandinavia, Denmark, and England.^1-7 Responses of laboratory animals (in which experimental neuroses were produced by various techniques), and of human subjects and patients, supported the claim that benactyzine hydrochloride, in persons with and without psychological disorders reduces autonomic reaction to induced emotion, thereby producing a state of emotional and physical relaxation, without drowsiness. Benactyzine hydrochloride raises the threshold for external stimuli, so that the patient, in a state of tension arising from excessive strain, no longer reacts to stimuli which previously would have provoked marked irritation. He feels as . . . [Full Text PDF of this Article]

Author Affiliations
Cincinnati

Footnotes
Submitted for publication March 1, 1957.

SUAVITIL is the trademark of Merck Sharp & Dohme, Division of Merck & Co., Inc. Suavitil, benactyzine hydrochloride, 1 mg. tablets were supplied by Merck Sharp & Dohme Research Laboratories, West Point, Pa.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?